FIGURE

Fig. 5

ID

ZDB-FIG-240229-111

Publication

Shi et al., 2023 - FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

FGF19 influences ANXA2 expression to accelerate angiogenesis. A: ANXA2 expression in HUVECs with the increasing doses of FGF19. B: The interference efficiency of shANXA2 was assessed by western blotting in HUVECs. C, D: Tube formation assays (top) and Transwell migration assays (bottom) were performed to measure tube formation and migration of HUVECs transfected with shNC or shANXA2. E: Western blotting was used to detect ANXA2 expression with the treatment of FGF19 or shANXA2. F: Tube formation assays (top) and Transwell migration assays (bottom) were performed to measure tube formation and migration of HUVECs. G, H: The relative tube length and migrated HUVECs were quantified. I: HUVECs transfected with shANXA2 or shNC and pretreated with FGF19 were mixed with Matrigel for subcutaneous injection. Top: Gross observation of angiogenesis in Matrigel plugs. Bottom: H&E staining was performed to observe blood vessel formation in different groups. Data represent the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Oncol (Dordr)